Mangalam Drugs & Organics Limited announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced total revenue was INR 626.026 million compared to INR 486.282 million a year ago. Net income was INR 16.513 million compared to net loss of INR 44.198 million a year ago. Basic earnings per share was INR 1.04 compared to basic loss per share of INR 2.79 a year ago. For the nine months, total revenue was INR 1,949.869 million compared to INR 1,796.021 million a year ago. Net income was INR 31.985 million compared to net loss of INR 20.236 million a year ago. Basic earnings per share was INR 2.02 compared to basic loss per share of INR 1.28 a year ago.